Mayo Clinic BioPharma Diagnostics to attend 2022 AACC


Mayo Clinic BioPharma Diagnostics executives will attend the upcoming AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago July 24-28 to share with attendees the clinical and research capabilities of Mayo Clinic BioPharma Diagnostics.

Powered by Mayo Clinic Laboratories’ expansive testing menu, BioPharma Diagnostics provides in vitro diagnostic-specific services to support medical device, biopharma, and diagnostic companies through analytical validation of new assays and devices.

BioPharma Diagnostics is inspired by Mayo Clinic’s history of collaboration and breaking down barriers to change medicine. That’s why we bring Mayo Clinic expertise and quality to each project — offering a wide range of laboratory testing to support all phases of your clinical trials. Together we have the power to improve global health.

BioPharma Diagnostics partners gain access to Mayo Clinic Laboratories’ core competencies, including:

  • The world’s most sophisticated subspecialty test menu
  • Experienced physicians, scientists, and researchers who care for and study patients with some of the most complex illnesses
  • Strategic and tactical support at every stage of the R&D process
  • Expertise in quality and standardization programs

Sign up to connect with BioPharma Diagnostics at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo.

Meghann Southwick (@meghannsouthwick)

Meghann Southwick